🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/12/2002 | 55,73 | 55,73 | 54,33 | 54,54 | -2,11% | 2,50% | 6.181.733 |
| 11/12/2002 | 56,31 | 56,32 | 55,42 | 55,72 | -1,03% | 1,59% | 6.034.908 |
| 10/12/2002 | 56,07 | 56,75 | 55,63 | 56,30 | +0,43% | 1,99% | 5.687.810 |
| 09/12/2002 | 54,40 | 56,97 | 54,40 | 56,06 | +0,31% | 4,72% | 7.758.973 |
| 06/12/2002 | 55,73 | 56,36 | 55,39 | 55,89 | -1,11% | 1,73% | 6.739.269 |
| 05/12/2002 | 57,01 | 57,16 | 55,82 | 56,52 | +0,66% | 2,34% | 8.936.820 |
| 04/12/2002 | 55,78 | 56,49 | 55,39 | 56,15 | +0,03% | 1,97% | 8.799.532 |
| 03/12/2002 | 56,36 | 56,46 | 52,63 | 56,13 | -1,88% | 6,79% | 25.408.446 |
| 02/12/2002 | 57,68 | 57,68 | 56,49 | 57,20 | +0,91% | 2,07% | 6.655.010 |
| 29/11/2002 | 57,17 | 57,24 | 56,42 | 56,69 | -0,82% | 1,44% | 3.142.009 |
| 27/11/2002 | 56,49 | 57,48 | 56,32 | 57,16 | +2,18% | 2,06% | 6.379.595 |
| 26/11/2002 | 56,87 | 57,25 | 55,55 | 55,94 | -2,80% | 2,99% | 8.019.191 |
| 25/11/2002 | 56,99 | 57,71 | 56,68 | 57,55 | +2,17% | 1,81% | 8.217.473 |
| 22/11/2002 | 56,25 | 57,03 | 56,20 | 56,33 | +0,36% | 1,48% | 9.071.698 |
| 21/11/2002 | 56,77 | 56,77 | 55,44 | 56,13 | +2,33% | 2,35% | 10.822.591 |
| 20/11/2002 | 54,97 | 55,55 | 53,98 | 54,85 | -0,23% | 2,86% | 8.887.564 |
| 19/11/2002 | 53,97 | 55,33 | 53,63 | 54,97 | +1,86% | 3,16% | 8.078.927 |
| 18/11/2002 | 53,32 | 54,29 | 52,91 | 53,97 | +2,15% | 2,59% | 6.693.157 |
| 15/11/2002 | 51,59 | 52,85 | 51,55 | 52,83 | +2,65% | 2,53% | 8.281.610 |
| 14/11/2002 | 50,39 | 51,70 | 49,92 | 51,47 | +2,16% | 3,52% | 8.597.373 |
| 13/11/2002 | 51,62 | 52,47 | 49,43 | 50,38 | -3,68% | 5,90% | 13.138.986 |
| 12/11/2002 | 52,59 | 53,04 | 51,92 | 52,31 | -0,38% | 2,14% | 6.116.966 |
| 11/11/2002 | 53,34 | 53,50 | 52,17 | 52,51 | -1,59% | 2,50% | 5.238.323 |
| 08/11/2002 | 52,88 | 53,87 | 52,67 | 53,36 | +0,90% | 2,27% | 7.123.570 |
| 07/11/2002 | 52,75 | 53,42 | 52,73 | 52,88 | -1,04% | 1,30% | 7.455.472 |
| 06/11/2002 | 51,73 | 54,01 | 51,73 | 53,44 | +3,32% | 4,41% | 15.335.594 |
| 05/11/2002 | 51,23 | 51,90 | 50,57 | 51,72 | +0,97% | 2,59% | 7.923.299 |
| 04/11/2002 | 51,81 | 52,58 | 51,10 | 51,22 | -0,70% | 2,85% | 7.671.360 |
| 01/11/2002 | 51,05 | 52,19 | 50,69 | 51,58 | -0,33% | 2,95% | 7.383.370 |
| 31/10/2002 | 51,76 | 52,39 | 51,24 | 51,76 | +0,00% | 2,21% | 6.750.692 |